Nasus Pharma Stock Alpha and Beta Analysis
| NSRX Stock | 9.15 1.36 17.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Nasus Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Nasus Pharma over a specified time horizon. Remember, high Nasus Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Nasus Pharma's market risk premium analysis include:
Beta 0.61 | Alpha 0.0227 | Risk 4.78 | Sharpe Ratio 0.12 | Expected Return 0.58 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Nasus Pharma Backtesting, Nasus Pharma Valuation, Nasus Pharma Correlation, Nasus Pharma Hype Analysis, Nasus Pharma Volatility, Nasus Pharma History and analyze Nasus Pharma Performance. Nasus Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Nasus Pharma market risk premium is the additional return an investor will receive from holding Nasus Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nasus Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Nasus Pharma's performance over market.| α | 0.02 | β | 0.61 |
Nasus Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Nasus Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Nasus Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Nasus Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Nasus Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nasus Pharma shares will generate the highest return on investment. By understating and applying Nasus Pharma stock market price indicators, traders can identify Nasus Pharma position entry and exit signals to maximize returns.
Nasus Pharma Return and Market Media
The median price of Nasus Pharma for the period between Fri, Oct 3, 2025 and Thu, Jan 1, 2026 is 7.5 with a coefficient of variation of 7.01. The daily time series for the period is distributed with a sample standard deviation of 0.51, arithmetic mean of 7.28, and mean deviation of 0.44. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | AptarGroup Evaluating Value After Expanded Nasus Pharma Intranasal Epinephrine Partnership - simplywall.st | 10/16/2025 |
2 | How strong dollar benefits Nasus Pharma Ltd. Ordinary Shares stock - Gap Down Entry and Exit Point Strategies - newser.com | 10/30/2025 |
3 | Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder | 11/06/2025 |
4 | What makes Nasus Pharma Ltd. Ordinary Shares stock appealing to growth investors - July 2025 Highlights Capital Protection Trade Alerts - newser.com | 11/11/2025 |
5 | How strong dollar benefits Nasus Pharma Ltd. Ordinary Shares stock - Product Launch Reliable Price Action Trade Plans - newser.com | 11/14/2025 |
6 | Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed | 11/18/2025 |
7 | What makes Nasus Pharma Ltd. Ordinary Shares stock appealing to growth investors - 2025 Retail Activity Precise Swing Trade Entry Alerts - Newser | 12/03/2025 |
8 | Nasus Pharma CEO Issues 2025 Letter to Shareholders | 12/22/2025 |
About Nasus Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Nasus or other stocks. Alpha measures the amount that position in Nasus Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nasus Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nasus Pharma's short interest history, or implied volatility extrapolated from Nasus Pharma options trading.
Build Portfolio with Nasus Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Nasus Stock Analysis
When running Nasus Pharma's price analysis, check to measure Nasus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nasus Pharma is operating at the current time. Most of Nasus Pharma's value examination focuses on studying past and present price action to predict the probability of Nasus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nasus Pharma's price. Additionally, you may evaluate how the addition of Nasus Pharma to your portfolios can decrease your overall portfolio volatility.